HB Fuller (FUL) Stock Rating Lowered by Deutsche Bank

Deutsche Bank downgraded shares of HB Fuller (NYSE:FUL) from a buy rating to a hold rating in a research note issued to investors on Tuesday, February 5th, Marketbeat.com reports. Deutsche Bank currently has $50.00 price objective on the specialty chemicals company’s stock.

Other equities analysts also recently issued reports about the stock. Stifel Nicolaus started coverage on shares of HB Fuller in a report on Monday, December 10th. They issued a buy rating and a $62.00 price target on the stock. Zacks Investment Research downgraded shares of HB Fuller from a hold rating to a sell rating in a report on Monday, November 19th. Finally, ValuEngine raised shares of HB Fuller from a sell rating to a hold rating in a report on Tuesday, January 22nd. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating and three have issued a buy rating to the stock. HB Fuller presently has an average rating of Hold and a consensus price target of $59.00.

NYSE:FUL traded up $0.57 during mid-day trading on Tuesday, hitting $51.05. 283,315 shares of the company’s stock were exchanged, compared to its average volume of 466,917. The company has a debt-to-equity ratio of 1.86, a current ratio of 1.99 and a quick ratio of 1.34. HB Fuller has a fifty-two week low of $39.61 and a fifty-two week high of $59.58. The company has a market cap of $2.59 billion, a PE ratio of 17.02, a P/E/G ratio of 0.81 and a beta of 1.44.

HB Fuller (NYSE:FUL) last posted its earnings results on Wednesday, January 16th. The specialty chemicals company reported $0.90 EPS for the quarter, missing the consensus estimate of $0.99 by ($0.09). The business had revenue of $768.43 million for the quarter, compared to analyst estimates of $806.99 million. HB Fuller had a return on equity of 13.77% and a net margin of 5.63%. The company’s revenue was up 13.3% on a year-over-year basis. Equities research analysts expect that HB Fuller will post 3.3 EPS for the current year.

The company also recently declared a quarterly dividend, which was paid on Thursday, February 21st. Stockholders of record on Thursday, February 7th were issued a $0.155 dividend. This represents a $0.62 dividend on an annualized basis and a dividend yield of 1.21%. The ex-dividend date of this dividend was Wednesday, February 6th. HB Fuller’s payout ratio is 20.67%.

In related news, VP Timothy J. Keenan sold 13,205 shares of the company’s stock in a transaction that occurred on Tuesday, February 12th. The shares were sold at an average price of $48.32, for a total value of $638,065.60. Following the transaction, the vice president now directly owns 38,435 shares in the company, valued at $1,857,179.20. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, VP Robert J. Martsching sold 3,215 shares of the company’s stock in a transaction that occurred on Friday, February 15th. The stock was sold at an average price of $48.86, for a total transaction of $157,084.90. The disclosure for this sale can be found here. Corporate insiders own 3.46% of the company’s stock.

Hedge funds have recently bought and sold shares of the stock. State of Alaska Department of Revenue boosted its stake in shares of HB Fuller by 1.8% during the fourth quarter. State of Alaska Department of Revenue now owns 16,948 shares of the specialty chemicals company’s stock valued at $723,000 after purchasing an additional 300 shares during the period. Whittier Trust Co. of Nevada Inc. lifted its position in HB Fuller by 16.5% during the fourth quarter. Whittier Trust Co. of Nevada Inc. now owns 2,643 shares of the specialty chemicals company’s stock valued at $113,000 after buying an additional 375 shares during the period. Piedmont Investment Advisors Inc. lifted its position in HB Fuller by 3.5% during the fourth quarter. Piedmont Investment Advisors Inc. now owns 12,063 shares of the specialty chemicals company’s stock valued at $515,000 after buying an additional 404 shares during the period. Bank of Montreal Can lifted its position in HB Fuller by 6.1% during the fourth quarter. Bank of Montreal Can now owns 7,686 shares of the specialty chemicals company’s stock valued at $328,000 after buying an additional 442 shares during the period. Finally, Advisor Group Inc. lifted its position in HB Fuller by 52.8% during the fourth quarter. Advisor Group Inc. now owns 1,497 shares of the specialty chemicals company’s stock valued at $64,000 after buying an additional 517 shares during the period. Institutional investors own 99.09% of the company’s stock.

HB Fuller Company Profile

H.B. Fuller Company, together with its subsidiaries, formulates, manufactures, and markets adhesives, sealants, coatings, polymers, tapes, encapsulants, and other specialty chemical products worldwide. The company operates through five segments: Americas Adhesives, EIMEA, Asia Pacific, Construction Adhesives, and Engineering Adhesives.

See Also: What is the Consumer Price Index (CPI)?

Analyst Recommendations for HB Fuller (NYSE:FUL)

Receive News & Ratings for HB Fuller Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HB Fuller and related companies with MarketBeat.com's FREE daily email newsletter.